蘑菇传媒

College of Osteopathic Medicine Assistant Professor Eleanor Yusupov, D.O., has been featured in a 聽blog post noting the key differences between weight-loss medications Zepbound and Mounjaro. While both are FDA-approved using active ingredient tirzepatide, the nuances of each make them better suited for different patients.

鈥淢ounjaro is approved for individuals with type 2 diabetes, while Zepbound is approved for weight loss and obstructive sleep apnea in people with obesity,鈥� explains Yusupov, an obesity medicine physician. 鈥淶epbound is different鈥�because it [mimics] two gut hormones鈥擥LP-1 and GIP.鈥�